Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_assertion type Assertion NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_head.
- NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_assertion description "[Data suggest that SPRY2, an inhibitor of ERK signaling, may be bypassed in melanoma cells either by down-regulation of its expression in WT BRAF cells, or by the presence of the BRAF mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_provenance.
- NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_assertion evidence source_evidence_literature NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_provenance.
- NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_assertion SIO_000772 15313890 NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_provenance.
- NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_assertion wasDerivedFrom lhgdn-20090331 NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_provenance.
- NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_assertion wasGeneratedBy ECO_0000203 NP206405.RAHeQBKMPBKuaXCOH5ifZl3yD8B_oS4EwsnzXDD2cJha0130_provenance.